Atlas Trials

Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis

Clinical trial NCT00263315 · COMPLETED

Trial details

NCT number
NCT00263315
Sponsor
Erasmus Medical Center
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Aspergillosis
Start date
2000-01-01
Enrollment
320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.